Navigation Links
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Date:8/5/2008

sing compounds through clinical development and closer to commercialization," said Mr. Krayacich. "I have committed my career to the development of novel therapies that address unmet patient needs and I'm excited about the innovative candidates in the Marinus pipeline."

About Marinus Pharmaceuticals

Marinus Pharmaceuticals is a privately held specialty pharmaceutical company that is dedicated to the identification, development, and commercialization of novel drugs to treat serious neurological, psychiatric and pain disorders. Its lead compound, ganaxolone, is a synthetic analog of the neurosteroid allopregnanolone (3a,5a-P), a metabolite of progesterone. It is currently being investigated in a Phase IIb clinical trial as a potential treatment of epilepsy in children (infantile spasms) and complex partial seizures in adults. Chelerythrine is currently in pre-clinical development for the treatment of bipolar disorder and the cognitive deficits of schizophrenia. Marinus' investors include Domain Associates, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners. For additional information, please visit http://www.marinuspharma.com.

About Domain Associates

Domain Associates, LLC is a venture capital firm focused on health care product opportunities including biopharmaceuticals, medical devices and related businesses. Over its 23 year history, Domain has been involved in the creation of over 200 companies. Its latest venture capital fund is Domain Partners VII, L.P., which is capitalized at $700 million. Domain is located in Princeton, NJ and in San Diego, CA. For more information, please visit http://www.domainvc.com.

About Canaan Partners Healthcare

Canaan Partners invests in visionary entrepreneurs and provides them the networks, insights and operational guidance required to build high-performance technolog
'/>"/>

SOURCE Marinus Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
2. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
3. Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
4. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
5. Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
6. VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress
7. Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
8. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
9. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
10. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP)
11. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 Pressure BioSciences, ... that the Company will host a teleconference to discuss ... a business update. The teleconference information is provided below: ... a.m. Eastern Daylight Time (EDT) Dial-in: (800) ... (302) 607-2001 (Int,l) Passcode: VS22823 For those ...
(Date:5/23/2013)... SynCardia Systems, Inc. ( http://www.syncardia.com ), manufacturer of ... CE (Europe) approved Total Artificial Heart, announced today that ... than 380,000 visitors annually, is featuring the SynCardia ... portable driver as part of its $3 million Bodyworks ... kind. , “BodyWorks combines the latest technology with ...
(Date:5/23/2013)... St. Louis, Missouri (PRWEB) May 23, 2013 ... design and manufacture of complete thermal systems, recently ... more than 90 years of experience in designing ... most complete selection of products to serve diverse ... lead-time options is featured at the beginning of ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Industry ... Alexandria, VA for the Oak Ridge National ... will take place at the Hilton Alexandria Mark ... Biodetection Technologies 2013 conference on June 18 ... Participating: , AdSave, American Elements, Applied Research Associates, ...
Breaking Biology Technology:Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3Watlow Introduces Its New Industrial Heater Catalog 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 3Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 4Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 5
... DIEGO, Oct. 27 Ardea Biosciences, Inc. (Nasdaq: ... and chief executive officer, will present at the Oppenheimer 21st ... scheduled to present at 10:50 a.m. EDT on Tuesday, November ... and can be accessed on the Investor Relations section of ...
... Oct. 27 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... in China, announced today that Mr. Jacob Ho, Acting ... and Ms. Helen Yang, Investor Relations Manager, are scheduled ... held in early November. Goldman Sachs ...
... Oct. 26 Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ... overview at the Oppenheimer & Co. 21st Annual Healthcare Conference ... the Waldorf Astoria, New York City. The ... accessed under "Calendar of Events" in the Idenix Investor Center ...
Cached Biology Technology:Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference 2Sinovac Participates in Two Investor Conferences in November 2
(Date:5/22/2013)... to genetic engineering drastically reduces the time and ... the workhorses of biotechnology, scientists are reporting. Published ... the method paves the way for more rapid ... cleanup and other activities. , Keith Shearwin and ... of the genetic material DNA into a bacterium,s ...
(Date:5/22/2013)... cellular DNA can endanger the whole organism, as they ... Ludwig-Maximilians-Universitaet (LMU) in Munich now report how byproducts of ... , The DNA in our cells controls the form ... The instructions for this are encoded in the linear ... bases adenine (A), cytosine (C), guanine (G) and thymine ...
(Date:5/22/2013)... provide important new details on how climate change will ... 21 in the Journal of Animal Ecology . ... predictions and informing policymakers of how species are likely ... "There is a growing recognition among biologists that climate ... and that this is going to have very important ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... on the messages it receives from its genome. Sometimes messages are ... these delayed messages are stored and eventually marked for destruction in ... are message protectors, according to a paper by Boag et al. ... Journal of Cell Biology . In a separate study Noble et ...
... variants responsible for body shape. Based on work in ... the open access journal BMC Genetics identifies ... key determinant of weight. As the prevalence of ... there is considerable effort being devoted to identify genetic ...
... polar opposite diseases, but both depend upon dopamine in ... drug addicts get too much of it. Although the ... known, the way it works has been a mystery. ... Medicine has revealed that dopamine strengthens and weakens the ...
Cached Biology News:Unlocking mystery of why dopamine freezes Parkinson's patients 2Unlocking mystery of why dopamine freezes Parkinson's patients 3
... Dr. P Set from different human ... More organs maybe available upon request. ... items from the whole set, and ... price. All Dr. P Set ...
... of buffer and fixative results in ... In Vivo Manual Perfusion Fixation System ... buffer and fixative results in complete ... and clean--Complete system with everything down ...
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
... The steadylite plus assay system ... assay sensitivity, Designed for batch-processing ... for higher density microplates such ... Odor free, Convenient storage conditions ...
Biology Products: